Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...
Icelandic biotechnology company Alvotech intends to explore the possibility of a Stockholm listing as it announced the acquisition of a Swedish research and development operation and drug candidate.
Klarna Group plc has filed to raise $100 million in a U.S. IPO, although the final amount may be above $1 billion. Click here ...
On the heels of its IPO filing, Swedish fintech giant Klarna announced on Monday that it will exclusively provide buy now, ...
Hailed as the first Chinese company to launch a homegrown antibody drug conjugate (ADC), RemeGen has recently been battling a ...
Kicking off the week, PDP Shipping & Projects will open its IPO on Monday, March 10 and will close its bidding window on March 12. The company, which specialises in end-to-end logistics solutions ...
Three small IPOs are tentatively scheduled to list in the week ahead, while some other small deals may join the calendar throughout the week. Inflammation biotech Apimeds Pharmaceuticals US (APUS ...
MALAYSIA’S medical cost inflation of 12.6% in 2023, significantly higher than the global average of 5.6%, is indeed alarming. However, banning private hospitals from going public may not be the ...
Bayer is asking shareholders to authorize a potential equity offer that would allow it to quickly raise billions of euros to deal with ongoing Monsanto … ...
U.S. inflation data for February will be the highlight among economic data as investors continue to follow the back-and-forth of U.S. President Trump’s announcements on tariffs. A rate decision ...
The Indian IPO market has seen its fair share of highs and lows, and if there’s one thing GV Ravishankar, Managing Director at PeakXV Partners, has learned, it’s that taking a company public ...
March 7, 2025 (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces today's IPO's to watch in the Biotech, Technology, Homebuilder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback